Q-Plex™ Pneumococcal Kit (23-ple

Confirm delete?

Q-Plex™ Pneumococcal Kit (23-plex)

Zoom

Cat No: 34948

Assay Kits - More Assay Kits

Antibodies play an essential role in the protection against pneumococcal disease. In humans, serum antibodies typically act against the polysaccharide capsule in a serotype specific manner. There are multiple vaccination options for protection against...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Correlated keywords:

QPlex Streptococcus AntiPneumococcal

Product Overview:
Antibodies play an essential role in the protection against pneumococcal disease. In humans, serum antibodies typically act against the polysaccharide capsule in a serotype specific manner. There are multiple vaccination options for protection against S. pneumoniae, with the major difference being the number and composition of specific serotypes present in the vaccine. The Q-Plex™ Human Pneumococcal IgG (23-Plex) is a chemiluminescent multiplex ELISA run on two 96-well plates comprising the serotypes found in the Pneumovax®23 vaccine. A 14-Plex plate detects 14 of the common serotypes individuals are vaccinated against while the second detects 9 additional serotypes commonly used as vaccination targets. Limits for these assays were set using the 007sp Human Anti-Pneumococcal capsule Reference Serum. The Q-Plex™ Human Pneumococcal IgG (14-Plex) and Q-Plex™ Human Pneumococcal IgG (9-Plex) are also available for individual purchase. Requires the Q-View™ Chemiluminescent Imaging System Item No. 28264 for analysis. See Item No. 28264 to view pricing and specifications for the Q-View™ Imager LS. Species: Human Sample Type: Serum Sample Volume Required: 0.25 µl Estimated Assay Length: 3 hours Intra-Assay Cross Reactivity: High levels of 19F may inhibit the detection of 12F. No cross-reactivity or interference detected between other analytes. Assay Type: Indirect Detection Method: Chemiluminescent Multiplex Format: 96-well solid plate [QuanSys Catalog Nos. 23-Plex 481149HU; 14-Plex 481749HU; 9-Plex 481649HU ]

Size	1 ea
Shipping	wet ice
Custom Code	3822.19
UNSPSC code	41116104

Technical File

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.